Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis

Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis

Abstract Background The impact of corticosteroid therapy on outcomes of patients with coronavirus disease 2019 (COVID-19) is highly controversial. We aimed to compare the risk of death between COVID-19-related ARDS patients with corticosteroid treatment and those without. Methods In this single-cent...

Full description

Bibliographic Details
Main Authors: Chaomin Wu, Dongni Hou, Chunling Du, Yanping Cai, Junhua Zheng, Jie Xu, Xiaoyan Chen, Cuicui Chen, Xianglin Hu, Yuye Zhang, Juan Song, Lu Wang, Yen-cheng Chao, Yun Feng, Weining Xiong, Dechang Chen, Ming Zhong, Jie Hu, Jinjun Jiang, Chunxue Bai, Xin Zhou, Jinfu Xu, Yuanlin Song, Fengyun Gong
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Critical Care
Subjects:
Corticosteroids
Coronavirus disease 2019
Severe acute respiratory syndrome coronavirus 2
Mortality
Propensity score
Methylprednisolone
Online Access:http://link.springer.com/article/10.1186/s13054-020-03340-4

Internet

http://link.springer.com/article/10.1186/s13054-020-03340-4

Similar Items